HIF-1alpha, a Survival and Differentiation Factor for Cartilage
HIF-1alpha,软骨的存活和分化因子
基本信息
- 批准号:8609400
- 负责人:
- 金额:$ 34.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-26 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAngiogenic SwitchBiochemical ReactionBiologyBlood VesselsBone DevelopmentBone DiseasesBone RegenerationCartilageCartilage DiseasesCell DeathCell Differentiation processCell SurvivalCellsCessation of lifeChondrocytesChondrogenesisConsumptionDiseaseEnsureEnzymesEpiphysial cartilageExtracellular MatrixFetal GrowthGeneticGrantHIF1A geneHomeostasisHypoxiaImpairmentIn VitroInvestigationIschemiaKnockout MiceKnowledgeLeadLearningLimb BudMalignant NeoplasmsMediatingMediator of activation proteinMesenchymalMesenchymal DifferentiationMesenchymeMetabolicMitochondriaMoldsMolecularNull LymphocytesOxygenPhysical condensationReportingRespirationRespiratory ChainRoleSignal TransductionStagingTestingTissuesbasebonecartilage developmentcartilage regenerationhypoxia inducible factor 1in vivoinsightmouse modelmtTF1 transcription factormutantnovelpreventpublic health relevancesoft tissuetherapeutic targettranscription factor
项目摘要
ABSTRACT
Oxygen (O2) is not only an indispensable metabolic substrate in various enzymatic reactions including
mitochondrial respiration, but also a regulatory signal that controls stability and activity of !"#$transcription factor
Hypoxia Inducible Factor-1¿ (HIF-1¿), a key mediator of the cellular adaptation to low O2 tension (hypoxia). The
fetal growth plate is a unique mesenchymal tissue because it is avascular, albeit it requires the angiogenic switch in
order to be replaced by bone. Over the years, we have demonstrated that, consistent with its avascularity, the fetal
growth plate has an inner hypoxic region. We have provided genetic evidence that HIF-1¿ is a survival factor for
hypoxic chondrocytes in vivo. We have shown that mesenchymal condensations of the limb bud are also hypoxic,
and lack of HIF-1¿ in limb bud mesenchyme delays differentiation of mesenchymal cells into chondrocytes in vivo.
In this grant, we propose to identify the molecular mechanisms that mediate the role of HIF-1¿ as a survival
and differentiation factor in cartilage in vivo. Along these lines, we have reported that viable chondrocytes at the
periphery of HIF-1¿ null growth plates and HIF-1¿ null mesenchymal condensations of the limb bud are
considerably more hypoxic than controls. Moreover, we have provided genetic evidence that the extreme hypoxia
of HIF-1¿ null cells is not the consequence of reduced availability of O2 to the growth plate. Therefore, we
hypothesized it had to be the consequence of increased O2 consumption. Our hypothesis is in line with the well-
documented ability of HIF-1¿ to impair mitochondrial respiration in vitro. Based on these findings, we now propose
that a key function of HIF-1¿ is to reduce O2 consumption in cells that are already hypoxic because of limited
availability of O2, in order to prevent them from becoming virtually anoxic, a status that is not compatible with cell
survival and differentiation. Specifically, we hypothesize that HIF-1¿ is essential for survival of hypoxic
chondrocytes and for timely differentiation of hypoxic mesenchymal cells into chondrocytes by negatively
regulating mitochondrial respiration, and thus mitochondrial O2 consumption. We will test our hypothesis by
inhibiting mitochondrial respiration in HIF-1¿ null chondrocytes (Specific Aim I) and in HIF-1¿ null mesenchymal
cells of the limb bud (Specific Aim II) in vivo and in vitro. Moreover, we will establish whether HIF-1¿ lowers O2
consumption in chondrocytes in vitro (Specific Aim III). Our findings may lead to a paradigm shift if we
determine that, differently from what has been reported in the context of well-oxygenated tissues,
impairment of mitochondrial respiration is an indispensable requirement for survival and for early
differentiation stages of hypoxic chondrocytes.
$
抽象的
氧(O2)不仅是各种酶促重新发挥的必不可少的代谢底物
线粒体呼吸,也是控制和稳定性和活动的调节信号
低氧诱导因子1。 (Hif-1),一种对低O2张力的细胞适应(缺氧)的关键介体
胎儿生长板是ACH间充质组织,尽管它需要血管生成开关
为了被骨头代替,我们已经证明,与胎儿一致
生长板有较低的调节。是一个生存因素
体内缺氧软骨细胞。
缺乏HIF-1?在肢体中,间充质延迟了间充质细胞在体内分为chonedrocytes。
在这项赠款中,我们建议确定介导HIF-1»作用的分子机制。作为生存
和体内软骨的区分因子。
HIF-1的外围无效生长板和HIF-1?肢体芽的空间充质凝结为
此外,我们还提供了比对照的高度缺氧。
hif-1¿零细胞并不是O2对生长板的可用性降低的结果
假设这必须是O2消耗增加的努力。
HIF-1的记录能力为了基于发现,我们提出了线粒体呼吸。
HIF-1的关键功能是为了减少细胞中的O2消耗,这是Allyady低氧元件的
O2的可用性,以防止它们具有虚拟性缺氧,该状态与CELEST兼容
生存与区分。对于低氧生存至关重要
软骨细胞和及时的低氧分化
调节Mitchondrial呼吸,从而调节线粒体O2的消耗。
抑制HIF-1中的线粒体呼吸空软骨细胞(特定目标I)和HIF-1中空间充质
肢体芽的细胞(特定的目标II)在体内和体外,我们将确定HIF-1?降低O2
体外软骨细胞的消费(特定的目标III)。
确定,与在氧化组织良好的组织背景下报道的情况不同,
线粒体呼吸的损害是生存的必不可少的要求,并且
低氧软骨细胞的区分阶段。
$
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amato J. Giaccia其他文献
Benzamides substitués et leurs utilisations
苯甲酰胺替代品和用途
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
M. Bonnet;Denise A. Chan;Amato J. Giaccia;Michael Patrick Hay;Edwin W. Lai;Olga V. Razorenova;Connie Sun;Ray Tabibiazar;Po - 通讯作者:
Po
Amato J. Giaccia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amato J. Giaccia', 18)}}的其他基金
Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
- 批准号:
10707880 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Project 1: Inhibition of Complement C5aR1 Radioprotects Normal Tissue and Radiosensitizes Tumors
项目 1:抑制补体 C5aR1 辐射保护正常组织并使肿瘤辐射增敏
- 批准号:
10334199 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Preclinical Testing of a Novel Therapy Targeting AXL in Advanced Kidney Cancer
针对晚期肾癌 AXL 的新疗法的临床前测试
- 批准号:
8949353 - 财政年份:2016
- 资助金额:
$ 34.65万 - 项目类别:
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
- 批准号:
10212325 - 财政年份:2015
- 资助金额:
$ 34.65万 - 项目类别:
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
HIF 抑制线粒体和脂质积累对肿瘤生长的影响
- 批准号:
9976465 - 财政年份:2015
- 资助金额:
$ 34.65万 - 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
- 批准号:
8492949 - 财政年份:2011
- 资助金额:
$ 34.65万 - 项目类别:
Regulation of Tumor and Metastatic Growth by Hypoxia and CTGF
缺氧和 CTGF 对肿瘤和转移性生长的调节
- 批准号:
8208641 - 财政年份:2011
- 资助金额:
$ 34.65万 - 项目类别:
相似国自然基金
线粒体应激促进肿瘤第一条新生血管(Angiogenic Switch)生成的作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
“补肺健脾活血法”调节血管生成开关抑制哮喘气道血管重塑机制研究
- 批准号:81804026
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
组织凝血因子III启动血管生成开关对丹参抑制休眠肿瘤恶变的作用机制
- 批准号:81703765
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于血管生成开关-Nrf2/ARE通路调控的促血管新生与土家医"理阴化毒"干预血管性痴呆作用机理研究
- 批准号:81473797
- 批准年份:2014
- 资助金额:72.0 万元
- 项目类别:面上项目
相似海外基金
Developing a Temporally-Regulated Gene Therapy for Therapeutic Angiogenesis
开发用于治疗性血管生成的时间调控基因疗法
- 批准号:
10535141 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Human endothelial cell heterogeneity and activation in atherosclerosis
动脉粥样硬化中的人内皮细胞异质性和激活
- 批准号:
10534283 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Developing a Temporally-Regulated Gene Therapy for Therapeutic Angiogenesis
开发用于治疗性血管生成的时间调控基因疗法
- 批准号:
10832458 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别:
Human endothelial cell heterogeneity and activation in atherosclerosis
动脉粥样硬化中的人内皮细胞异质性和激活
- 批准号:
10707010 - 财政年份:2022
- 资助金额:
$ 34.65万 - 项目类别: